Next Article in Journal
Plasmin-Induced Activation of Human Platelets Is Modulated by Thrombospondin-1, Bona Fide Misfolded Proteins and Thiol Isomerases
Next Article in Special Issue
Phytochemicals in Gynecological Cancer Prevention
Previous Article in Journal
Effect of Acute Sprint Exercise on Myokines and Food Intake Hormones in Young Healthy Men
Previous Article in Special Issue
Natural Agents Targeting Mitochondria in Cancer
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
IJMS
Volume 21
Issue 22
10.3390/ijms21228850
ijms-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Correction to Int. J. Mol. Sci. 2020, 21(17), 6357.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Shi, H., et al. Arctigenin Attenuates Breast Cancer Progression through Decreasing GM-CSF/TSLP/STAT3/β-Catenin Signaling. Int. J. Mol. Sci. 2020, 21, 6357

by
Hui Shi
1,
Luping Zhao
2,
Xinlin Guo
2,
Runping Fang
3,
Hui Zhang
1,
Guanjun Dong
1,
Jia Fu
1,
Fenglian Yan
1,
Junfeng Zhang
1,
Zhaochen Ning
1,
Qun Ma
1,
Zhihua Li
1,
Chunxia Li
1,
Jun Dai
1,
Chuanping Si
1,* and
Huabao Xiong
1,*
1
Institute of Immunology and Molecular Medicine, Jining Medical University, Jining 272067, China
2
Institute of Basic Medical College, Jining Medical University, Jining 272067, China
3
State Key Laboratory of Medicinal Chemical Biology, Department of Biochemistry, College of Life Sciences, Nankai University, Tianjin 300071, China
*
Authors to whom correspondence should be addressed.
Int. J. Mol. Sci. 2020, 21(22), 8850; https://doi.org/10.3390/ijms21228850
Submission received: 15 November 2020 / Accepted: 18 November 2020 / Published: 23 November 2020
(This article belongs to the Special Issue Bioactive Phytochemicals for Cancer Prevention and Treatment II)
Browse Figure
Versions Notes
The authors wish to make the following correction to this paper [1]. The reason for the correction is an error in representing β-catenin immunohistochemical staining pictures in the old version of Figure 6F. The mistake was due to mislinking two pictures from the same slide for two different groups. They should be replaced with the correct new figure (Figure 1).
The correction does not change the conclusions of this manuscript. The authors would like to apologize for any inconvenience caused to the readers by these changes.

Conflicts of Interest

The authors declare no conflict of interest.

Reference

  1. Shi, H.; Zhao, L.; Guo, X.; Fang, R.; Zhang, H.; Dong, G.; Fu, J.; Yan, F.; Zhang, J.; Ning, Z.; et al. Arctigenin Attenuates Breast Cancer Progression through Decreasing GM-CSF/TSLP/STAT3/beta-Catenin Signaling. Int. J. Mol. Sci. 2020, 21, 6357. [Google Scholar] [CrossRef]
Ijms 21 08850 g001 550
Figure 1. Arctigenin inhibits breast cancer progression via decreasing GM-CSF and TSLP in vivo. (A) Kaplan–Meier survival curves for mice injected with the indicated 4T1 cells and/or treated with arctigenin. oe, overexpression. n = 6 mice/group. *** p < 0.01, ns, not significant, p > 0.05 (Log Rank test). (B) The tumor volume of 4T1 tumors separated from mice of each group. (C) The tumor weight of separated 4T1 tumors in each group. (D) Representative Ki-67 staining (left panel) and statistics (right panel) of 4T1 tumors from the indicated mice. Scale bar, 100 μm. (E) The levels of GM-CSF, TSLP, p-STAT3, STAT3, β-catenin and cyclin D1 of the indicated tumors from representative mice were analyzed by Western blotting analysis. Mouse number was indicated at bottom. (F) Representative immunohistological staining of GM-CSF, TSLP, β-catenin and cyclin D1 in the indicated tumor sections. Scale bar, 100 μm. For (B)–(D) (right panel) and (E), the data are shown as mean ± SD. Statistically significant differences are indicated: * p < 0.05, ** p < 0.01, *** p < 0.001, ns, not significant, and p > 0.05 (One-way ANOVA).
Figure 1. Arctigenin inhibits breast cancer progression via decreasing GM-CSF and TSLP in vivo. (A) Kaplan–Meier survival curves for mice injected with the indicated 4T1 cells and/or treated with arctigenin. oe, overexpression. n = 6 mice/group. *** p < 0.01, ns, not significant, p > 0.05 (Log Rank test). (B) The tumor volume of 4T1 tumors separated from mice of each group. (C) The tumor weight of separated 4T1 tumors in each group. (D) Representative Ki-67 staining (left panel) and statistics (right panel) of 4T1 tumors from the indicated mice. Scale bar, 100 μm. (E) The levels of GM-CSF, TSLP, p-STAT3, STAT3, β-catenin and cyclin D1 of the indicated tumors from representative mice were analyzed by Western blotting analysis. Mouse number was indicated at bottom. (F) Representative immunohistological staining of GM-CSF, TSLP, β-catenin and cyclin D1 in the indicated tumor sections. Scale bar, 100 μm. For (B)–(D) (right panel) and (E), the data are shown as mean ± SD. Statistically significant differences are indicated: * p < 0.05, ** p < 0.01, *** p < 0.001, ns, not significant, and p > 0.05 (One-way ANOVA).
Ijms 21 08850 g001
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Shi, H.; Zhao, L.; Guo, X.; Fang, R.; Zhang, H.; Dong, G.; Fu, J.; Yan, F.; Zhang, J.; Ning, Z.; et al. Correction: Shi, H., et al. Arctigenin Attenuates Breast Cancer Progression through Decreasing GM-CSF/TSLP/STAT3/β-Catenin Signaling. Int. J. Mol. Sci. 2020, 21, 6357. Int. J. Mol. Sci. 2020, 21, 8850. https://doi.org/10.3390/ijms21228850

AMA Style

Shi H, Zhao L, Guo X, Fang R, Zhang H, Dong G, Fu J, Yan F, Zhang J, Ning Z, et al. Correction: Shi, H., et al. Arctigenin Attenuates Breast Cancer Progression through Decreasing GM-CSF/TSLP/STAT3/β-Catenin Signaling. Int. J. Mol. Sci. 2020, 21, 6357. International Journal of Molecular Sciences. 2020; 21(22):8850. https://doi.org/10.3390/ijms21228850

Chicago/Turabian Style

Shi, Hui, Luping Zhao, Xinlin Guo, Runping Fang, Hui Zhang, Guanjun Dong, Jia Fu, Fenglian Yan, Junfeng Zhang, Zhaochen Ning, and et al. 2020. "Correction: Shi, H., et al. Arctigenin Attenuates Breast Cancer Progression through Decreasing GM-CSF/TSLP/STAT3/β-Catenin Signaling. Int. J. Mol. Sci. 2020, 21, 6357" International Journal of Molecular Sciences 21, no. 22: 8850. https://doi.org/10.3390/ijms21228850

APA Style

Shi, H., Zhao, L., Guo, X., Fang, R., Zhang, H., Dong, G., Fu, J., Yan, F., Zhang, J., Ning, Z., Ma, Q., Li, Z., Li, C., Dai, J., Si, C., & Xiong, H. (2020). Correction: Shi, H., et al. Arctigenin Attenuates Breast Cancer Progression through Decreasing GM-CSF/TSLP/STAT3/β-Catenin Signaling. Int. J. Mol. Sci. 2020, 21, 6357. International Journal of Molecular Sciences, 21(22), 8850. https://doi.org/10.3390/ijms21228850

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop